Skip to main content
RYM
NASDAQ Industrial Applications And Services

RYTHM Q2 Revenue Jumps 73% to $23M, Turns Profitable, but Pulls Guidance on Regulatory Uncertainty

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Engineering & Construction Stocks · Industrial
Sentiment info
Neutral
Importance info
7
Price
$20.65
Mkt Cap
$44.999M
52W Low
$14
52W High
$53.65
52W Position info
47% above low
Off High info
62% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

RYM sits 47% above its 52-week low of $14 on elevated volume (1.9× avg).

Summary

RYTHM posted Q2 2026 revenue of $23 million, up 73% sequentially, with net income of $1.2 million and record THC beverage depletions. The company withdrew its Q3 outlook due to federal regulatory uncertainty effective November 2026.


Key Events · Earnings and Guidance · RYM

  • Revenue Surges 73% Sequentially

    Q2 2026 revenue reached $23.0 million, up from $13.3 million in Q1 2026, driven by the first full quarter of a $70 million annual licensing agreement and accelerating THC beverage sales.

  • Swings to Net Profit

    Net income was $1.2 million, or $0.09 per share, compared to a $7.2 million loss a year ago, aided by a $1.2 million income tax benefit.

  • Record THC Beverage Depletions

    THC beverage depletions hit a record ~25,000 cases in June 2026 across 18 states, up from ~7,000 in June 2025, reflecting strong consumer demand in traditional retail channels.

  • Cash Flow Turns Positive

    Cash from operations was $8.7 million for the quarter, boosting cash and equivalents to $41.9 million at quarter-end.


Analysis · RYM · Industrial Applications And Services

A breakout quarter saw revenue leap 73% sequentially to $23 million, swinging the company to a $1.2 million net profit and generating $8.7 million in operating cash flow. THC beverage depletions reached a record 25,000 cases, and the $70 million annual licensing deal with Green Thumb is now fully contributing. Yet the company withdrew its Q3 outlook, citing the looming November 2026 federal ban on hemp-derived THC products — a regulatory cliff that overshadows strong operational momentum and could threaten the core growth engine.

How filings like this one have moved

In the 30 days to Oct 18, 2026, 29.6% of the 1460 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RYM was trading at $20.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $45M. The 52-week trading range was $14.00 to $53.65. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RYM - Latest Insights

RYM
Oct 16, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.32
Real-time Price: $17.16 info
Change: -$2.16 (-11%) info
Market Cap: $37.394M info
RYM
Sep 03, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $25.04
Real-time Price: $17.16 info
Change: -$7.88 (-31%) info
Market Cap: $37.394M info
RYM
Aug 11, 2026, 8:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $20.95
Real-time Price: $17.16 info
Change: -$3.79 (-18%) info
Market Cap: $37.394M info
RYM
Aug 11, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $21.00
Real-time Price: $17.16 info
Change: -$3.84 (-18%) info
Market Cap: $37.394M info
RYM
Aug 04, 2026, 7:10 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $20.65
Real-time Price: $17.16 info
Change: -$3.49 (-17%) info
Market Cap: $37.394M info